Stock CHRS COHERUS BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Coherus BioSciences, Inc.

Equities

CHRS

US19249H1032

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
1.82 USD -3.19% Intraday chart for Coherus BioSciences, Inc. -4.71% -45.35%
May. 23 Coherus Biosciences, Inc. Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-Chemokine Receptor 8 Antibody, CHS-114, at the 2024 American Society of Clinical Oncology Annual Meeting CI
May. 13 Truist Securities Trims Price Target on Coherus BioSciences to $7 From $8, Maintains Buy Rating MT
688f3f03424310703d690e4784babe14.vydcksUfSrOw037e2FQqe43DBsjWdQSQ-IIo7KguqU0.619u2Oh5ItjJhSuZ7A5bVuyharmFJlPxyfBYldFFkQv7YxHGvHQc0N21Mw~024e3fb3a532a282741d40f3ab9c6458
  1. Stock Market
  2. Equities
  3. CHRS Stock
  4. Charts Coherus BioSciences, Inc.
  5. News Chart